Kevin M. Connolly - President and CEO

Kevin Connolly is a serial entrepreneur who has spent his career in the medical device industry, including the last fifteen (15) years in urology and women’s health. Mr. Connolly founded Vesiflo, Inc. in 2012 to further develop and commercialize the inFlow device. He is also President and CEO of another device company called Personal Med Corp. Previously, Mr. Connolly was Founder and CEO of SRS Medical Systems, Inc. of Billerica MA, where he acquired and developed a comprehensive product line for the treatment of incontinence and other voiding disorders, including some of the most innovative urodynamic systems in the industry. SRS Medical is now owned by Schooner Capital. Mr. Connolly has obtained numerous patents, FDA device clearances, has twice presented to the MCAC (Medicare) Executive Committee concerning urology procedures and he has obtained a CPT Category I reimbursement code. He has also personally executed eight (8) acquisitions of bladder-related technologies. Prior to that, Mr. Connolly was Founder and CEO of Davicon, Inc. Of Burlington MA, a manufacturer of medical instruments that he sold to a group of private investors.


Susan Robinson - Chief Business Officer

Ms. Robinson has over 20 years experience in the biotech industry. Most recently she was CEO and a Director of Targeted Genetics Corporation, a publicly traded therapeutic R&D stage biotech company. She completed the sale of this company in 2011. Prior to this role she held business development roles at Targeted Genetics and earlier at Genzyme Molecular Oncology. In her business development roles she was integral to strategic planning efforts for these companies and completed numerous academic and corporate technology licenses, sponsored research agreements, pharma/biotech product development, and manufacturing collaborations. In addition, she has experience with asset and company sales and acquisitions. Earlier in her career Ms. Robinson held investor/corporate communications roles for biotech companies adding public and private financing experience and communication with buy and sellside analysts to her experience base. Ms. Robinson received a B.S. in Biology from Yale University.

Terence Moore - EVP Marketing / Sales

Mr. Moore has 30 years experience in the medical device industry, with more than half devoted to the urology and gynecology sectors. He has specialized in driving adoption of new technologies and therapies in varied sales and marketing capacities for start-up, early-stage and established companies. Mr. Moore was a principal architect of the sales and marketing organization for Influence, Inc., the developers of the inFlow device. He later played pivotal roles in the integration of Influence into American Medical Systems (AMS) and in the strategic positioning of AMS within the female pelvic health market. In addition to his work for Conceptus, Endocare and HealthTronics, Mr. Moore has capital equipment experience outside the UroGyn sector selling infusion pumps and surgical lasers.


John W. Sullivan - CFO

Mr. Sullivan has more than 15 years experience in operational healthcare finance as well as banking transactional experience in capital raising and M&A. He was the Director of Research at Healthios, a Chicago based healthcare investment bank where in addition to deal experience, he grew the research department as a platform for both marketing and deal execution. Prior experience includes the CFO position at Pharos Innovations, a remote patient monitoring company, and as an equity research analyst at Lehman. Mr. Sullivan has an MBA and is a CPA.


T. Loran Van Noy - General Manager of Long Term Care Division

Mr. Van Noy is a senior medical products executive with decades of experience in both large multi-national firms and startups. He was most recently General Manager/Sr. Director of U.S. operations for Fukuda Denshi Co. Ltd., a $1B+ worldwide medical instrumentation company headquartered in Tokyo, Japan. Prior to that, he was CEO of Lucent Medical Systems of Kirkland WA, a medical device company funded by Becton Dickinson. Before that, Mr. Van Noy was CEO of Diagnostic Ultrasound Corporation (now Verathon of Bothell WA), manufacturer of the BladderScan,® the industry standard for ultrasonic measurements of bladder volume, and President of Kinetic Concepts, Inc. (KCI) of San Antonio TX, now a $950M public company that provides world-wide rentals and sales of therapeutic/life support equipment to the acute and extended care clinical markets.